• 보험의학회지
• /
• 제32권2호
• /
• pp.33-38
• /
• 2013

Coronary artery diseases are very important agenda in the insurance medicine. Insurance medicine is defined as using medical knowledge for insurance administration such as underwriting, claims, and customer satisfaction. This review article contains review of coronary artery disease in terms of insurance medicine. Estimation of extra-risks for acute myocardial infarction are MR of 349% and EDR of 41‰. In medical underwriting, individual life applicants can be assessed by Framingham's CHD risk assessment model. In claims, medical claims review is a useful method of consulting for claims staffs. Several diagnostic criteria of acute myocardial infarction are introduced in time. The universal definition of myocardial infarction by ESC/ACCF/WHF was demonstrated the most valuable predictor of 10-year mortality. Contents for State-Of-The-Art of the coronary artery disease are current antithrombotics. There are many novel anti-thrombotic agents such as ticagrelol, dabigatran, rivaroxaban, and pegnivacogin.

• 보험의학회지
• /
• 제1권1호
• /
• pp.54-56
• /
• 1984

• 보험의학회지
• /
• 제31권1호
• /
• pp.29-33
• /
• 2012

Nowadays, obstructive sleep apnea is being important to life insurance industry. Many life applicants submit their attending physician's statement, diagnostic certificate, and results of polysomnography to underwriters. So It's necessary to perform evidence-based medical approach. I hope this article is helpful to insurance doctors and underwriters.

• 보험의학회지
• /
• 제23권
• /
• pp.16-31
• /
• 2004

• 보험의학회지
• /
• 제7권1호
• /
• pp.68-83
• /
• 1988

• 보험의학회지
• /
• 제27권1호
• /
• pp.14-17
• /
• 2008

• 보험의학회지
• /
• 제2권1호
• /
• pp.45-52
• /
• 1985

• 보험의학회지
• /
• 제21권
• /
• pp.121-139
• /
• 2002

• 보험의학회지
• /
• 제21권
• /
• pp.55-60
• /
• 2002

• 보험의학회지
• /
• 제19권
• /
• pp.91-103
• /
• 2000